Dow Down 1.29% Nasdaq Down 3.25%

Gilead Sciences Inc. (GILD)

-NasdaqGS
85.14 Down 1.54(1.78%) Feb 5, 4:00PM EST
|After Hours : 85.01 Down 0.13 (0.15%) Feb 5, 7:45PM EST
Prev Close:86.68
Open:86.68
Bid:84.30 x 200
Ask:85.24 x 300
1y Target Est:118.63
Beta:1.40682
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:84.45 - 88.02
52wk Range:81.89 - 123.37
Volume:15,732,823
Avg Vol (3m):10,533,700
Market Cap:121.07B
P/E (ttm):7.15
EPS (ttm):11.91
Div & Yield:1.72 (2.02%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 1.78%121.07B
GSKDown 0.54%98.64B
PFEUp 0.10%179.22B

Key Statistics

Forward P/E (1 yr):6.78
P/S (ttm):3.78
Ex-Dividend Date:14-Dec-15

Analysts

Annual EPS Est (Dec-16) :12.25
Quarterly EPS Est (Mar-16) :3.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.72

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback